Swedbank’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.3M | Buy |
503,502
+73,805
| +17% | +$9.28M | 0.07% | 196 |
|
|
2025
Q1 | $47.5M | Buy |
429,697
+421,400
| +5,079% | +$46.6M | 0.06% | 213 |
|
|
2024
Q4 | $1.13M | Sell |
8,297
-5,715
| -41% | -$780K | ﹤0.01% | 649 |
|
|
2024
Q3 | $1.61M | Hold |
14,012
| – | – | ﹤0.01% | 627 |
|
|
2024
Q2 | $1.93M | Hold |
14,012
| – | – | ﹤0.01% | 612 |
|
|
2024
Q1 | $1.93M | Buy |
14,012
+6,768
| +93% | +$933K | 0.02% | 474 |
|
|
2023
Q4 | $954K | Hold |
7,244
| – | – | ﹤0.01% | 637 |
|
|
2023
Q3 | $815K | Hold |
7,244
| – | – | ﹤0.01% | 629 |
|
|
2023
Q2 | $683K | Hold |
7,244
| – | – | ﹤0.01% | 649 |
|
|
2023
Q1 | $733K | Hold |
7,244
| – | – | ﹤0.01% | 651 |
|
|
2022
Q4 | $865K | Hold |
7,244
| – | – | ﹤0.01% | 632 |
|
|
2022
Q3 | $769K | Hold |
7,244
| – | – | ﹤0.01% | 653 |
|
|
2022
Q2 | $706K | Hold |
7,244
| – | – | ﹤0.01% | 670 |
|
|
2022
Q1 | $679K | Hold |
7,244
| – | – | ﹤0.01% | 700 |
|
|
2021
Q4 | $613K | Hold |
7,244
| – | – | ﹤0.01% | 717 |
|
|
2021
Q3 | $695K | Hold |
7,244
| – | – | ﹤0.01% | 704 |
|
|
2021
Q2 | $705K | Hold |
7,244
| – | – | ﹤0.01% | 706 |
|
|
2021
Q1 | $704K | Buy |
+7,244
| New | +$704K | ﹤0.01% | 699 |
|